1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. CDK
  4. CDK5 Inhibitors

CDK5 Inhibitors

CDK1

CDK2

CDK3

CDK4

CDK5

CDK6

CDK7

CDK8

CDK9

CDK11

CDK12

CDK13

CDK14

CDK16

CDK19

CDC

CLK

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform CDK5 together.

Please try each isoform separately.

CDK5 Specific Inhibitors
Product Name CDK5 CDK1 CDK2 CDK3 CDK4 CDK6 CDK7 CDK9 CDK14 CDK16 CDK5 Selectivity Purity
Abemaciclib methanesulfonate
Cdk5/p25, IC50: 355 nM
CDK5/p35, IC50: 287 nM
CDK1/cyclinB1, IC50: 1627 nM
CDK2/cyclinE, IC50: 504 nM
 
Cdk4/cyclin D1, IC50: 2 nM
CDK6/cyclinD1, IC50: 10 nM
CDK7/Mat1/cyclinH1, IC50: 3910 nM
CDK9/cyclinT1, IC50: 57 nM
    Pan Inhibitor 99.95%
Dinaciclib
CDK5, IC50: 1 nM
CDK1, IC50: 3 nM
CDK2, IC50: 1 nM
       
CDK9, IC50: 4 nM
    Pan Inhibitor 99.73%
Seliciclib
CDK5/p35, IC50: 0.16 μM
cdc2/cyclin B, IC50: 0.65 μM
cdk2/cyclin A, IC50: 0.7 μM
Cdk2/cyclin E2, IC50: 0.7 μM
              Pan Inhibitor 99.94%
Abemaciclib
CDK5/p35, IC50: 287 nM
Cdk5/p25, IC50: 355 nM
CDK1/cyclinB1, IC50: 1627 nM
CDK2/cyclinE, IC50: 504 nM
 
Cdk4/cyclin D1, IC50: 2 nM
CDK6/cyclinD1, IC50: 10 nM
CDK7/Mat1/cyclinH1, IC50: 3910 nM
CDK9/cyclinT1, IC50: 57 nM
    Pan Inhibitor 99.69%
AZD-5438
cdk5-p25, IC50: 14 nM
cdk1-cyclin B1, IC50: 16 nM
cdk2-cyclin E, IC50: 6 nM
cdk2-cyclin A, IC50: 45 nM
 
cdk4-cyclin D1, IC50: 449 nM
cdk6-cyclin D3, IC50: 21 nM
cdk7-cyclin H, IC50: 821 nM
cdk9-cyclin T, IC50: 20 nM
    Pan Inhibitor 99.37%
AT7519
CDK5/p35, IC50: 13 nM
Cdk1/cyclin B, IC50: 210 nM
cdk2/cyclin A, IC50: 47 nM
 
Cdk4/cyclin D1, IC50: 100 nM
cdk6/cyclin D3, IC50: 170 nM
CDK7/Cyclin H/MAT1, IC50: 2400 nM
CDK9/Cyclin T, IC50: 10 nM
    Pan Inhibitor 98.15%
GSK 3 Inhibitor IX
CDK5/p35, IC50: 80 nM
Cdk1/cyclin B, IC50: 320 nM
cdk2/cyclin A, IC50: 300 nM
 
Cdk4/cyclin D1, IC50: 10 μM
          Pan Inhibitor 99.66%
PHA-767491 hydrochloride
CDK5, IC50: 460 nM
CDK1, IC50: 250 nM
CDK2, IC50: 240 nM
       
CDK9, IC50: 34 nM
    Pan Inhibitor 99.91%
Purvalanol A
cdk5-p35, IC50: 75 nM
cdc2-cyclin B, IC50: 4 nM
cdk2-cyclin E, IC50: 35 nM
cdk2-cyclin A, IC50: 70 nM
 
cdk4-cyclin D1, IC50: 850 nM
          Pan Inhibitor 98.66%
AT7519 Hydrochloride
CDK5/p35, IC50: 13 nM
Cdk1/cyclin B, IC50: 210 nM
cdk2/cyclin A, IC50: 47 nM
 
Cdk4/cyclin D1, IC50: 100 nM
cdk6/cyclin D3, IC50: 170 nM
CDK7/Cyclin H/MAT1, IC50: 2400 nM
CDK9/Cyclin T, IC50: 10 nM
    Pan Inhibitor 99.99%
Atuveciclib
CDK5/p35(h), IC50: 1600 nM
CDK1/CycB(h), IC50: 1100 nM
CDK2/CycE(h), IC50: 1000 nM
CDK3/CycE(h), IC50: 890 nM
     
CDK9/CycT1, IC50: 13 nM
CDK9/CycT1(h), IC50: 6 nM
    Pan Inhibitor 99.42%
Purvalanol B
CDK5/p35, IC50: 6 nM
cdc2/cyclin B, IC50: 6 nM
cyclin dependent kinase 1-cyclinB, IC50: 6 nM
cdk2/cyclin A, IC50: 6 nM
CDK2/cyclinE, IC50: 9 nM
 
Cdk4/cyclin D1, IC50: 10000 nM
          Pan Inhibitor >97.0%
Lerociclib dihydrochloride
CDK5/p35, IC50: 832 nM
Cdk5/p25, IC50: 1.2 μM
CDK1/cyclinB1, IC50: 2.4 μM
cdk2/cyclin A, IC50: 1.5 μM
CDK2/cyclinE, IC50: 3.6 μM
 
Cdk4/cyclin D1, IC50: 1 nM
cdk6/cyclin D3, IC50: 2 nM
CDK7/Cyclin H/MAT1, IC50: 2.4 μM
CDK9/Cyclin T, IC50: 28 nM
    Pan Inhibitor 98.45%
MC180295
cdk5-p35, IC50: 159 nM
cdk5-p25, IC50: 186 nM
CDK1-Cyclin B, IC50: 138 nM
cdk2-cyclin A, IC50: 233 nM
cdk2-cyclin E, IC50: 367 nM
CDK3-Cyclin E, IC50: 399 nM
CDK4-Cyclin D, IC50: 112 nM
cdk6-cyclin D3, IC50: 712 nM
CDK7-CycH/MAT1, IC50: 555 nM
CDK9- Cyclin T1, IC50: 5 nM
    Pan Inhibitor 98.47%
NG 52
Pho85p, IC50: 2 nM
cdc2-cyclin B, IC50: 0.34 μM
                Pan Inhibitor 99.93%
NVP-LCQ195
Cdk5/p25, IC50: 1 nM
CDK5/p35, IC50: 1 nM
Cdk1/cyclin B, IC50: 2 nM
cdk2/cyclin A, IC50: 2 nM
CDK2/cyclinE, IC50: 5 nM
CDK3/Cyclin E, IC50: 42 nM
 
cdk6/cyclin D3, IC50: 187 nM
CDK7/Cyclin H/MAT1, IC50: 3564 nM
CDK9/cyclinT1, IC50: 15 nM
    Pan Inhibitor 98.99%
JSH-150
Cdk5/p25, IC50: 4.64 μM
Cdk1/cyclin B, IC50: 1.34 μM
cdk2/cyclin A, IC50: 2.86 μM
     
CDK7/Cyclin H/MNAT1, IC50: 1.72 μM
CDK9/cyclinT1, IC50: 1 nM
CDK14/Cyclin Y, IC50: 1.68 μM
CDK16/Cyclin Y, IC50: 292 nM
Pan Inhibitor 92.04%
Alsterpaullone
CDK5/p35, IC50: 40 nM
Cdk1/cyclin B, IC50: 35 nM
cdk2/cyclin A, IC50: 15 nM
CDK2/Cyc E, IC50: 200 nM
              Pan Inhibitor 97.30%
AT7519 trifluoroacetate
CDK5/p35, IC50: 13 nM
Cdk1/cyclin B, IC50: 210 nM
cdk2/cyclin A, IC50: 47 nM
 
Cdk4/cyclin D1, IC50: 100 nM
cdk6/cyclin D3, IC50: 170 nM
CDK7/Cyclin H/MAT1, IC50: 2400 nM
CDK9/Cyclin T, IC50: 10 nM
    Pan Inhibitor 98.16%
BS-181 hydrochloride
CDK5/p35NCK, IC50: 3 μM
CDK1/cycB, IC50: 8.1 μM
CDK2/Cyc E, IC50: 0.88 μM
 
CDK4/Cyc D1, IC50: 33 μM
CDK6/cycD1, IC50: 47 μM
CDK7/CycH/MAT1, IC50: 0.021 μM
CDK9/cycT, IC50: 4.2 μM
    Pan Inhibitor
NU6140
cdk5-p25, IC50: 15 μM
CDK1-Cyclin B, IC50: 6.6 μM
cdk2-cyclin A, IC50: 0.41 μM
 
CDK4-Cyclin D, IC50: 5.5 μM
 
cdk7-cyclin H, IC50: 3.9 μM
      Pan Inhibitor >99.0%
Lerociclib
CDK5/p35, IC50: 0.832 μM
Cdk5/p25, IC50: 1.2 μM
CDK1/cyclinB1, IC50: 2.4 μM
cdk2/cyclin A, IC50: 1.5 μM
CDK2/cyclinE, IC50: 3.6 μM
 
Cdk4/cyclin D1, IC50: 1 nM
cdk6/cyclin D3, IC50: 2 nM
CDK7/Cyclin H/MAT1, IC50: 2.4 μM
CDK9/Cyclin T, IC50: 28 nM
    Pan Inhibitor
5-Iodo-indirubin-3'-monoxime
Cdk5/p25, IC50: 20 nM
Cdk1/cyclin B, IC50: 25 nM
                Pan Inhibitor
Indirubin-3'-monoxime-5-sulphonic acid
CDK5, IC50: 7 nM
CDK1, IC50: 5 nM
                Pan Inhibitor
Indirubin-5-sulfonate
CDK5/p35, IC50: 65 nM
Cdk1/cyclin B, IC50: 55 nM
cdk2/cyclin A, IC50: 35 nM
CDK2/cyclinE, IC50: 150 nM
 
Cdk4/cyclin D1, IC50: 300 nM
          Pan Inhibitor
PHA-767491
CDK5, IC50: 460 nM
CDK1, IC50: 250 nM
CDK2, IC50: 240 nM
       
CDK9, IC50: 34 nM
    Pan Inhibitor